NEW YORK, April 30, 2012 /PRNewswire/ -- Bernstein
Liebhard LLP is investigating whether the Board of Directors of
Gen-Probe Incorporated ("Gen-Probe" or the "Company") (NASDAQ:
GPRO) breached its fiduciary duty to its shareholders in agreeing
to sell Gen-Probe to Hologic, Inc. (NASDAQ: HOLX).
(Logo: http://photos.prnewswire.com/prnh/20120202/MM47134LOGO
)
Under the terms of the agreement, Gen-Probe shareholders will
receive $82.75 in cash for each share
they own. The investigation is focused on the potential
unfairness of the price to Gen-Probe shareholders and the process
by which the Gen-Probe Board of Directors considered and approved
the transaction.
If you are interested in discussing your rights as an Gen-Probe
stockholder, with no obligation or cost to you, please contact
U. Seth Ottensoser at:
(877) 779-1414
or
Ottensoser@bernlieb.com.
Bernstein Liebhard has pursued hundreds of securities, consumer
and shareholder rights cases and recovered over $3 billion for its clients. It has been
named to The National Law Journal's "Plaintiffs' Hot List"
in each of the last nine years.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
(877) 779-1414
www.bernlieb.com
ATTORNEY ADVERTISING. © 2012 Bernstein Liebhard LLP. The
law firm responsible for this advertisement is Bernstein Liebhard
LLP, 10 East 40th Street, New York, New
York 10016, (212) 779-1414. The lawyer responsible for
this advertisement in the State of
Connecticut is Michael S. Bigin. Prior results do not
guarantee or predict a similar outcome with respect to any future
matter.
SOURCE Bernstein Liebhard LLP